NPR news story
This past week has brought a dizzying back-and-forth about a U.S.-funded medical research trial.
Many public health experts call the study unethical and unnecessary, likening it to the infamous Tuskegee Experiment, while the Trump Administration has promoted it as a rare opportunity to study the potential negative effects of a vaccine.
The randomized controlled trial — funded partly with $1.6 million from the U.S. Centers for Disease Control and Prevention — would study the general health effects of the hepatitis B vaccine given at birth in the west African country of Guinea-Bissau.
For a relatively small study in a relatively remote place, there has been outsized attention, and the rumor mill has been spinning. There have been contradictory reports that the trial has already started, that it has been canceled and that it’s proceeding as planned.
This morning at a press conference, the Minister of Public Health in Guinea-Bissau, Quinhin Nantote, finally weighed in, saying the study is suspended pending review.
Read the full news story here.
SEE ALSO:
- Health Policy Watch: ‘Suspended or cancelled’: Guinea-Bissau Health Minister halts controversial hepatitis B trial
Source : NPR
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.